Akahoshi Tomohiko, Uehara Hideo, Tomikawa Morimasa, Kawanaka Hirofumi, Hashizume Makoto, Maehara Yoshihiko
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Center of Integration of Advanced Medicine, Life Science and Innovative Technology, Kyushu University, Fukuoka, Japan.
Asian J Endosc Surg. 2014 May;7(2):138-44. doi: 10.1111/ases.12096. Epub 2014 Feb 27.
Laparoscopic devascularization of the upper stomach and splenectomy (Dev+Sp), is technically difficult in patients with portal hypertension because of enlarged collateral vessels and spleen. This report presents the efficacy and safety of hand-assisted laparoscopic (HALS) Dev+Sp.
Ten patients underwent HALS Dev+Sp as a treatment for esophagogastric varices between 2005 and 2012 (HALS group). A vessel-sealing system was used for devascularization of vessels. An autosuture device was applied to dissect the splenic hilum and the left gastric and enlarged short gastric vessels. The operative and postoperative data were compared between patients who previously underwent laparoscopic Dev+Sp (LAP group, n = 9) and conventional Dev+Sp (OP group, n = 10) between 2001 and 2008.
The mean operative time was 328, 336, and 245 min (P < 0.05) and the mean blood loss was 1786, 981, and 250 mL (P < 0.05) in the OP, LAP, and HALS groups, respectively. Laparoscopic surgery was converted to HALS in one patient and to open surgery in three patients. There were no conversions in the HALS group. There was no significant difference in the cumulative recurrence rate and bleeding rate in the groups.
HALS Dev+Sp is a feasible and effective surgery in patients with portal hypertension.
对于门静脉高压患者,由于侧支血管和脾脏增大,腹腔镜下上腹部胃去血管化联合脾切除术(Dev+Sp)在技术上具有挑战性。本报告介绍了手辅助腹腔镜(HALS)Dev+Sp的疗效和安全性。
2005年至2012年期间,10例患者接受了HALS Dev+Sp治疗食管胃静脉曲张(HALS组)。使用血管封闭系统进行血管去血管化。应用自动缝合装置解剖脾门、胃左血管和增粗的胃短血管。将2001年至2008年期间接受过腹腔镜Dev+Sp(LAP组,n = 9)和传统Dev+Sp(OP组,n = 10)的患者的手术及术后数据进行比较。
OP组、LAP组和HALS组的平均手术时间分别为328、336和245分钟(P < 0.05),平均失血量分别为1786、981和250毫升(P < 0.05)。1例患者腹腔镜手术转为HALS,3例转为开放手术。HALS组无手术方式转换。各组间累积复发率和出血率无显著差异。
HALS Dev+Sp对于门静脉高压患者是一种可行且有效的手术。